Literature DB >> 24917082

Loss to follow-up in a cohort of HIV-infected patients in a regional referral outpatient clinic in Brazil.

Meire Cavalieri de Almeida1, Nayara de Jesus Pedroso, Maria do Socorro Lina van Keulen, Guillermo Patrício Ortega Jácome, Guilherme Côrtes Fernandes, Edna Massae Yokoo, Suely Hiromi Tuboi.   

Abstract

One of the main aspects related to non-adherence to combined antiretroviral therapy (cART) for patients infected with the Human Immunodeficiency Virus (HIV) refers to the abandonment of outpatient care. This study was aimed to estimate the loss to follow-up in outpatient HIV care at a Regional Referral Clinic (SAE) for HIV/AIDS in the city of Juiz de Fora, Brazil, and to identify associated factors and predictors. This is a prospective cohort of patients older than 18 years, under cART and regular outpatient care. The study included patients who attended medical visits during July-August 2011. Those who did not return to the clinic for new medical appointments within 90 days after the sixth month of follow up were considered lost to follow-up in outpatient care. Variables with P value ≤0.25 in the univariate analysis were included in a logistic regression model, adopting a significance level of 0.05. Among the 250 patients included in the study, 44 (17.6 %) were lost to follow up in outpatient care. Among these, 38 (86.4 %) were located in the cART delivery database system (SICLOM). Younger patients (≤43 versus >43 years) (OR 2.30 CI 1.06-5.00, P = 0.04), and patients attended by physician "E", when compared with physicians "A", "B", "C" or "D" (OR 5.90 CI 2.64-13.18, P = 0.00) were more likely to be lost to follow-up. Patients admitted in the service for 7 years or more were also more likely to be to lost to follow-up (OR 2.27 CI 1.2-4.4, P = 0.01), although this association did not remain statistically significant in the multivariate analysis. Although the purpose of the study, to identify individual factors associated to loss to follow-up, positives associations with a specific physician and with patients admitted in the service for 7 years or more suggest organizational factors. Although the majority of patients lost to follow-up in outpatient care were detected by SICLOM, a detectable viral load in most of these patients suggest a quality of outpatient HIV care proved ineffective, despite the availability of cART. We conclude on the need for further studies to investigate structural factors associated to loss to follow-up when enhanced retention strategies should be implemented in order to maintain an effective outpatient HIV care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24917082     DOI: 10.1007/s10461-014-0812-1

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  9 in total

1.  Treatment Outcomes of Brazilian Inmates with Treponema pallidum and Human Immunodeficiency Virus Infection: A Prospective Cohort Study.

Authors:  Graciela Mendonça Dos Santos Bet; Gleyce Hellen de Almeida de Souza; Júlio Croda; Maísa Estopa Correa; Romário Oliveira de Sales; Ruthe Aline da Silva Santos; Renata Viebrantz Enne Sgarbi; Renata Terumi Shiguematsu Yassuda; Ana Rita Coimbra Motta-Castro; Maurício Antônio Pompílio; Simone Simionatto
Journal:  Am J Trop Med Hyg       Date:  2018-05-03       Impact factor: 2.345

2.  Barriers along the care cascade of HIV-infected men in a large urban center of Brazil.

Authors:  Michael Hoffmann; Sarah MacCarthy; Ashley Batson; Ann Crawford-Roberts; Jennifer Rasanathan; Amy Nunn; Luis Augusto Silva; Ines Dourado
Journal:  AIDS Care       Date:  2015-08-20

3.  Baseline and Process Factors of Anti-Retroviral Therapy That Predict Loss to Follow-up Among People Living with HIV/AIDS in China: A Retrospective Cohort Study.

Authors:  Jinzhao Xie; Jing Gu; Xiuyuan Chen; Cong Liu; Haidan Zhong; Peishan Du; Quanmin Li; Joseph T F Lau; Chun Hao; Linghua Li; Yuantao Hao; Weiping Cai
Journal:  AIDS Behav       Date:  2021-10-26

4.  A Cross-Sectional Survey of HIV Testing and Prevalence in Twelve Brazilian Correctional Facilities.

Authors:  Renata Viebrantz Enne Sgarbi; Andrea da Silva Santos Carbone; Dayse Sanchez Guimarães Paião; Everton Ferreira Lemos; Simone Simionatto; Marco Antonio Moreira Puga; Ana Rita Coimbra Motta-Castro; Mauricio Antonio Pompilio; Juliana Urrego; Albert I Ko; Jason R Andrews; Julio Croda
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

5.  Loss to follow-up in anti-HCV-positive patients in a Brazilian regional outpatient clinic.

Authors:  L C Mendes; S M Ralla; A G Vigani
Journal:  Braz J Med Biol Res       Date:  2016-08-25       Impact factor: 2.590

6.  Large benefits to youth-focused HIV treatment-as-prevention efforts in generalized heterosexual populations: An agent-based simulation model.

Authors:  John E Mittler; James T Murphy; Sarah E Stansfield; Kathryn Peebles; Geoffrey S Gottlieb; Neil F Abernethy; Molly C Reid; Steven M Goodreau; Joshua T Herbeck
Journal:  PLoS Comput Biol       Date:  2019-12-17       Impact factor: 4.475

7.  Clinical Follow-Up in People Living with HIV During the COVID-19 Pandemic in Mexico.

Authors:  Ester Gutiérrez-Velilla; Alicia Piñeirúa-Menéndez; Santiago Ávila-Ríos; Nancy Patricia Caballero-Suárez
Journal:  AIDS Behav       Date:  2022-02-21

8.  The Effectiveness of a Pharmaceutical Care Model on Adherence to Antiretroviral Therapy: A SAME-Based Cohort Study in Brazil.

Authors:  Marli Gerenutti; Adriana Michel Vieira Martinez; Cristiane de Cassia Bergamaschi
Journal:  Adv Pharm Bull       Date:  2017-09-25

9.  Is substance use associated with HIV cascade outcomes in Latin America?

Authors:  Raquel B De Boni; Meridith B Peratikos; Bryan E Shepherd; Beatriz Grinsztejn; Claudia Cortés; Denis Padgett; Eduardo Gotuzzo; Pablo F Belaunzarán-Zamudio; Peter F Rebeiro; Stephany N Duda; Catherine C McGowan
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.